Healthcare Services US

US Regenerative Aesthetics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

US Regenerative Aesthetics Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Area, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $988.9 Mn Placeholder estimate
Estimate 2025 $1.08 Bn 39.8% of the global market
Projected 2034 $2.38 Bn 120.8% Adds $1.30 Bn over 9 forecast years
CAGR 2025–2034 9.2% Faster than 68% of 107 Healthcare Services markets here
Key players 5
  • US is 39.84% of the global market.
  • In North America, the largest is US (this report) at $1.08 Bn.
  • Fastest growing: Canada at 11% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.30 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Regenerative Aesthetics Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $988.9 Mn — —
2025 (base) $1.08 Bn +$91.0 Mn —
2026 (forecast) $1.18 Bn +$99.4 Mn +9.2%
2027 (forecast) $1.29 Bn +$108.5 Mn +19.2%
2028 (forecast) $1.41 Bn +$118.5 Mn +30.2%
2029 (forecast) $1.54 Bn +$129.4 Mn +42.2%
2030 (forecast) $1.68 Bn +$141.3 Mn +55.3%
2031 (forecast) $1.83 Bn +$154.3 Mn +69.6%
2032 (forecast) $2.00 Bn +$168.5 Mn +85.2%
2033 (forecast) $2.18 Bn +$184.0 Mn +102.2%
2034 (forecast) $2.38 Bn +$200.9 Mn +120.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Regenerative Aesthetics Market Analysis at a glance
Market size, 2025$1.08 Bn placeholder estimate
Forecast, 2034$2.38 Bn placeholder estimate
Growth (CAGR), 2025–20349.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTreatment, area and end user (see all)
Key playersGalderma S.A., Allergan, Merz Aesthetics, Croma Pharma, Benev (see all)
Active clinical trials1 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Regenerative Aesthetics Market Analysis Executive Summary

Regenerative aesthetics use treatments such as platelet-rich plasma, exosomes and biostimulators to repair and rejuvenate the skin.

Key segments of the regenerative Aesthetics market include treatment (Platelet-Rich Plasma, Biostimulatory Fillers and Exosome Therapy) and area (Face, Hair and Body).

Bar chart: US Regenerative Aesthetics market size, 2024–2034, placeholder estimates. $988.9 Mn in 2024, $1.08 Bn in 2025 and $2.38 Bn in 2034, 9.2% CAGR.
US Regenerative Aesthetics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Regenerative Aesthetics Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the regenerative Aesthetics market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the regenerative Aesthetics market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the regenerative Aesthetics market.

Competitive Landscape for Regenerative Aesthetics Market in US

The regenerative Aesthetics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Regenerative Aesthetics Market in US

Regenerative Aesthetics in the US: payment and research

Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[1] ClinicalTrials.gov lists 1 study on Regenerative Aesthetics that is recruiting, active or about to start in the US.⁠[2] People aged 65 and over: 18.4% of people in 2025, the latest World Bank figure for the US.⁠[3]

[1] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[2] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how regenerative Aesthetics services are delivered and paid for in US. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Regenerative Aesthetics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 18 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Regenerative Aesthetics in context

The US compared

  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[1]
  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[2]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[3]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Regenerative Aesthetics market in the US?
Placeholder estimate: about $1.08 Bn in 2025, rising to about $2.38 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Regenerative Aesthetics market in the US growing?
Placeholder estimate: about 9.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Regenerative Aesthetics market report cover?
The report splits the market by treatment (Platelet-Rich Plasma, Biostimulatory Fillers, Exosome Therapy, Microneedling), area (Face, Hair, Body) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Regenerative Aesthetics market?
Key players include Galderma S.A., Allergan, Merz Aesthetics, Croma Pharma and Benev.
What is driving the Regenerative Aesthetics market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the regenerative Aesthetics market. Older adults and their families are spending more on staying active and independent.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How many clinical trials on Regenerative Aesthetics are running in the US?
1 study is recruiting, active or about to start in the US, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
What does World Bank report for the US?
People aged 65 and over: 18.4% of people in 2025, the latest World Bank figure. Source: World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
How much research is published on Regenerative Aesthetics?
PubMed lists 48 papers on Regenerative Aesthetics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in US

See all

Related on aesthetics and skin and hair

See the topic